title: Introduction to direct oral anticoagulants and rationale for specific reversal agents.
authors.affiliation: Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA. Electronic address: charles.pollack@jefferson.edu.
authors.forename: Charles V
authors.initials: CV
authors.lastname: Pollack
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D000931:Antidotes; D001120:Arginine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015951:Factor Xa / Q000627:therapeutic use; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000931:Antidotes; C580915:PRT064445; D010879:Piperazines; D011994:Recombinant Proteins; D001120:Arginine; C000594745:idarucizumab; D015951:Factor Xa; C000593571:PER977